We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
Turnover
25.53%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+6.5%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.26B
AUM Growth
-$206M
(-5.9%)
Cap. Flow
-$341M
Cap. Flow
% of AUM
-10.46%
Top 10 Holdings %
Top 10 Hldgs %
26.55%
Holding
509
New
64
Increased
124
Reduced
220
Closed
65
Avg Time Held
1.5
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$54.3M |
| 2 |
PayPal
PYPL
|
+$46.4M |
| 3 |
Domino's
DPZ
|
+$42M |
| 4 |
Progressive
PGR
|
+$41.1M |
| 5 |
Intuit
INTU
|
+$39.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$50.8M |
| 2 |
O'Reilly Automotive
ORLY
|
+$46.6M |
| 3 |
F5
FFIV
|
+$44.2M |
| 4 |
Vistance Networks Inc
VISN
|
+$43.7M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$42.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.79% |
| 2 | Consumer Discretionary | 18.12% |
| 3 | Healthcare | 16.43% |
| 4 | Industrials | 12.91% |
| 5 | Communication Services | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
DELISTED
bluebird bio
BLUE
| $359K | 0.01% |
264
| – | – |
2017 Q1
1 quarter
|
|
227
Halozyme
HALO
$13.8B
| $346K | 0.01% |
26,980
-1,200
| -4% | -$16K |
2015 Q3
7 quarters
|
|
228
Kyntra Bio
KYNB
$21.7M
| $338K | 0.01% |
419
-4
| -0.9% | -$2.79K |
2015 Q3
7 quarters
|
|
|
BSTC
229
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $337K | 0.01% |
6,816
-2,972
| -30% | -$156K |
2014 Q1
13 quarters
|
|
230
MiMedx Group
MDXG
$683M
| $333K | 0.01% |
+22,240
| New | +$297K |
2017 Q2
0 quarters
|
|
231
Dana Inc
DAN
$3.06B
| $324K | 0.01% |
14,511
+2,350
| +19% | +$47.7K |
2015 Q1
9 quarters
|
|
|
BRSS
232
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $322K | 0.01% |
10,540
-4,880
| -32% | -$157K |
2015 Q4
6 quarters
|
|
233
Repligen
RGEN
$11.7B
| $321K | 0.01% |
7,739
+7,450
| +2,578% | +$283K |
2015 Q2
8 quarters
|
|
234
DELISTED
Amicus Therapeutics
FOLD
| $316K | 0.01% |
+31,400
| New | +$253K |
2017 Q2
0 quarters
|
|
|
CYOU
235
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $314K | 0.01% |
+8,090
| New | +$278K |
2017 Q2
0 quarters
|
|
236
Ennis
EBF
$568M
| $310K | 0.01% |
16,247
-6,862
| -30% | -$115K |
2015 Q4
6 quarters
|
|
237
Sarepta Therapeutics
SRPT
$1.88B
| $309K | 0.01% |
9,160
-100
| -1% | -$3.26K |
2016 Q4
2 quarters
|
|
238
Archrock
AROC
$5.13B
| $301K | 0.01% |
26,440
-12,070
| -31% | -$138K |
2016 Q2
4 quarters
|
|
239
Hackett Group
HCKT
$290M
| $301K | 0.01% |
19,417
-191,400
| -91% | -$3.24M |
2013 Q3
15 quarters
|
|
240
Stock Yards Bancorp
SYBT
$2.38B
| $301K | 0.01% |
7,745
-3,590
| -32% | -$139K |
2013 Q3
15 quarters
|
|
241
DELISTED
Radius Health, Inc.
RDUS
| $300K | 0.01% |
6,640
-300
| -4% | -$11.5K |
2016 Q1
5 quarters
|
|
242
First Financial Corp
THFF
$877M
| $298K | 0.01% |
6,300
-2,950
| -32% | -$140K |
2014 Q2
12 quarters
|
|
243
DELISTED
KEMET Corporation
KEM
| $292K | 0.01% |
22,810
-10,380
| -31% | -$132K |
2016 Q4
2 quarters
|
|
244
Pathward Financial
CASH
$1.5B
| $277K | 0.01% |
9,330
-4,260
| -31% | -$124K |
2016 Q4
2 quarters
|
|
|
RUTH
245
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $277K | 0.01% |
12,720
-5,980
| -32% | -$126K |
2013 Q3
15 quarters
|
|
246
US Physical Therapy
USPH
$1.28B
| $276K | 0.01% |
4,567
-2,070
| -31% | -$132K |
2013 Q2
16 quarters
|
|
247
DELISTED
ChemoCentryx, Inc.
CCXI
| $275K | 0.01% |
29,370
-13,380
| -31% | -$98.2K |
2016 Q4
2 quarters
|
|
248
American Public Education
APEI
$899M
| $261K | 0.01% |
11,040
-5,120
| -32% | -$117K |
2016 Q2
4 quarters
|
|
249
DELISTED
ARC Document Solutions, Inc.
ARC
| $257K | 0.01% |
61,870
-28,740
| -32% | -$107K |
2016 Q2
4 quarters
|
|
250
Bassett Furniture
BSET
$185M
| $256K | 0.01% |
6,740
-3,110
| -32% | -$93.2K |
2014 Q4
10 quarters
|
|
Similar funds
MAMU
PC
RG
DIA
Smith Group Asset Management's Q2 2017 Portfolio in Review
As of Q2 2017, Smith Group Asset Management held 509 positions worth $3.26B, down 5.9% from $3.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Smith Group Asset Management withdrew a net $341M in Q2 2017, closing 65 positions and reducing 220 holdings. Its most notable exit was Amgen, an estimated $50.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Smith Group Asset Management opened a new position in PayPal worth $50.6M.
- Smith Group Asset Management's largest Q2 2017 buy was PayPal: 943,700 shares worth $50.6M.
- Smith Group Asset Management added most to McDonald's in Q2 2017, an estimated $54.3M increase.
- Smith Group Asset Management's biggest Q2 2017 reduction was Hologic, cutting an estimated $24.6M.
- Smith Group Asset Management fully exited Amgen in Q2 2017, selling an estimated $50.8M.
- Smith Group Asset Management's ten largest holdings make up 27% of its $3.26B portfolio in Q2 2017.
- Smith Group Asset Management opened 64 new positions and closed 65 in Q2 2017.
- Smith Group Asset Management's portfolio value fell 5.9% quarter-over-quarter to $3.26B.
Based on Smith Group Asset Management's 13F filing for Q2 2017, filed 2 Aug 2017.